SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4fmg'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GMK_A_DVAA8_0
(GRAMICIDIN A)
4fmg VP1
(Human
polyomavirus
5)
3 / 4 VAL A 318
TRP A 123
TRP A 317
None
1.34A 1gmkA-4fmgA:
undetectable
1gmkB-4fmgA:
undetectable
1gmkA-4fmgA:
5.18
1gmkB-4fmgA:
5.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)
4fmg VP1
(Human
polyomavirus
5)
5 / 12 VAL A 311
ILE A 168
GLY A 169
GLY A 170
ILE A  55
None
0.75A 1hxbA-4fmgA:
undetectable
1hxbA-4fmgA:
16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZGY_A_BRLA503_1
(PEROXISOME
PROLIFERATOR
ACTIVATED RECEPTOR
GAMMA)
4fmg VP1
(Human
polyomavirus
5)
5 / 12 GLY A 169
SER A 285
LEU A  57
LEU A 108
LEU A 220
None
1.23A 1zgyA-4fmgA:
undetectable
1zgyA-4fmgA:
23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DTJ_A_THRA401_0
(ASPARTOKINASE)
4fmg VP1
(Human
polyomavirus
5)
4 / 8 GLY A 274
GLU A 124
ALA A 125
ASN A 240
None
0.72A 2dtjA-4fmgA:
undetectable
2dtjB-4fmgA:
undetectable
2dtjA-4fmgA:
22.53
2dtjB-4fmgA:
22.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJT_B_017B101_1
(PROTEASE)
4fmg VP1
(Human
polyomavirus
5)
5 / 11 VAL A 311
ILE A 168
GLY A 170
THR A  53
ILE A  55
None
0.91A 4njtA-4fmgA:
undetectable
4njtA-4fmgA:
15.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJT_D_017D101_1
(PROTEASE)
4fmg VP1
(Human
polyomavirus
5)
5 / 11 VAL A 311
ILE A 168
GLY A 170
THR A  53
ILE A  55
None
0.92A 4njtC-4fmgA:
undetectable
4njtC-4fmgA:
15.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RVJ_B_478B101_1
(HIV-1 PROTEASE)
4fmg VP1
(Human
polyomavirus
5)
5 / 11 VAL A 311
ILE A 168
GLY A 170
THR A  53
ILE A  55
None
0.96A 4rvjA-4fmgA:
undetectable
4rvjA-4fmgA:
15.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RVJ_D_478D101_1
(HIV-1 PROTEASE)
4fmg VP1
(Human
polyomavirus
5)
5 / 11 VAL A 311
ILE A 168
GLY A 170
THR A  53
ILE A  55
None
0.95A 4rvjC-4fmgA:
undetectable
4rvjC-4fmgA:
15.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4W5N_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
4fmg VP1
(Human
polyomavirus
5)
4 / 4 TYR A  79
THR A  78
GLY A 304
LEU A 138
None
0.95A 4w5nA-4fmgA:
undetectable
4w5nA-4fmgA:
15.03